Incidence and risk factors for herpes simplex virus type 2 seroconversion among pregnant women in Uganda: A prospective study | Zendy

Sarah Nakubulwa | Zendy; Dan K. Kaye | Zendy; Freddie Bwanga | Zendy; Nazarius Mbona Tumwesigye | Zendy; Moses Joloba | Zendy; Florence Mirembe | Zendy

Open Access

Incidence and risk factors for herpes simplex virus type 2 seroconversion among pregnant women in Uganda: A prospective study

Author(s) -

Sarah Nakubulwa,

Dan K. Kaye,

Freddie Bwanga,

Nazarius Mbona Tumwesigye,

Moses Joloba,

Florence Mirembe

Publication year - 2016

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.6874

Subject(s) - seroconversion , serostatus , medicine , pregnancy , incidence (geometry) , herpes simplex virus , obstetrics , immunology , viral load , virus , biology , physics , optics , genetics

Herpes simplex virus type 2 (HSV-2) acquired during pregnancy is associated with adverse outcomes such as perinatal HSV-2 transmission. HSV-2 seroconversion occurs within four weeks of HSV-2 acquisition. There was neither documented incidence nor risk factors for HSV-2 seroconversion during pregnancy in Uganda. The objective of this study was to determine the incidence and risk factors for HSV-2 seroconversion among pregnant women in Mulago Hospital, Uganda.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research